A Phase III, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of BMS-188667 vs Placebo in Subjects with Active Rheumatoid Arthritis on Background DMARDS Who Have Failed Anti-TNF Therapy

Authors
Category Primary study
ReportClinical Study Report IM01029 2004
Year 2004
Loading references information
This article has no abstract
Epistemonikos ID: 62499c47558ffc8b81c7121a2d9e4f5acd16186a
First added on: Oct 26, 2017